Terry Chen

• Lead regional Search & Evaluation efforts to identify external innovation opportunities across JAPAC • Manage in- and out-licensing projects across multiple markets in JAPAC region • Oversee alliance management for active partnerships • Drive external innovation initiatives in priority markets, collaborating with local and global stakeholders • Lead strategic assessments and BD execution across key therapeutic areas

• Responsible for strategy development and implementation • Launched crucial partnerships and reached licensing agreements with life science and digital health companies • Developed strategic partnerships with governments and national key hospitals, setting up joint ventures and projects • Led new product launches of clinical business • Led deal sourcing, investment opportunity development and portfolio management in data and diagnostics field • Led market research project to assess opportunities in rare disease, reproductive health, oncology and pharmacogenomics, and managed annual planning and quarterly board meetings • Designed go-to-market strategies to rapidly scale the clinical business and improve profitability and drive commercial strategy & operation implementation

• Led commercial excellence and new product planning, covering the scope of business strategy, access strategy, hospital targeting and launch readiness • Developed partnership with digital health companies and launched national program • Led planning and initiatives for sales forecasting, territory design and resource allocation and monitored sales execution • Rebuilt and automated the performance tracking system and redesigned incentive system for key account team and retail BU, with listing number increased 103% and retail YTD growth rate achieved 19% during 2016 • Redesigned key account model and led the organization restructure to improve key account’s Lilly potential coverage from 54% to 59% and DIA potential coverage from 26% to 46% • Transformed the business model of retail BU to increase pharmacy coverage from 13,500 to 20,250 without HC increase • Awarded "2017 Lilly CA Best Partner"

• Found and developed the digital health platform for hospital rounds and service partnership • Built the partnerships with CHFPC to incorporate the platform with referral system

• Sloan School of Management: New Enterprises, Technology and Entrepreneurial Sales, Metrics for Managers: Big Data, Managing in Adversity, Practical Leadership

• Selected as Executive Committee Member of Turnaround Management & Restructuring Club and Private Equity & Venture Capital Club in London Business School • Selected as Chair in Venture Capital Investment Competition 2014, inviting major VCs and entrepreneurs, organizing internal VC competition in LBS with 180+ participants and holding European VC Competition with participants from 10+ Business Schools • GMAT Score: 740 • CFA level 3 candidate

• Harvard Business School: Online Economy, Corporate Strategy and Entrepreneurship • Harvard Kennedy School of Government: Management in a Development Context

• Selected as Delegate of China by United Nations Headquarters to Global Model United Nations Conference 2009 (Geneva Switzerland) • “Best Delegate Award” Winner of Asian International Model United Nations Conference 2009 • Local Committee President of AIESEC • Project Manager of Enactus • School Debate Team member